A Rapid Response Research and Innovation programme to help respond to the COVID-19 pandemic has been developed by the government’s research and innovation agencies.
Joint Rapid Response Call
Science Foundation Ireland (SFI), Enterprise Ireland (EI), and IDA Ireland launched a joint rapid response call in March to fund research, development, and innovation (RD&I) activities to deliver significant and timely impact for Ireland within the context of the current emergency. The call was closely co-ordinated with the rapid response call launched by the Health Research Board (HRB) and the Irish Research Council (IRC).
Phase 2 Call
As Ireland looks beyond the initial response to the pandemic and to economic and societal recovery, significant research is required to better understand, mitigate and recover from the impact of COVID-19, and to enhance our readiness and resilience for future resurgences of the virus or other public health emergencies.
The COVID-19 Rapid Response Funding Call (Phase 2) aims to support research in a number of thematic areas focused on advancing our knowledge of the virus and its impact on our health, and developing solutions that contribute to economic and societal recovery.
The initial rapid response call resulted in more than 500 applications, with significant numbers of applications in areas of relevance to frontline healthcare, diagnostics, infection control, contact tracing and management of the mitigation measures related to social distancing and isolation.
Featured project: Inspire Research Group, NUI Galway
Related press releases
09 June 2020: Minister Humphreys announces 11 new COVID-19 research and innovation projects building on previous investment
29 April 2020: Government announces 26 new COVID-19 research and innovation projects to complement existing third-level research activity